Sign in

CIK 0001651625 · Accelerated filer

AC Immune SA

Sign in to watch
Ticker
ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
41 21 345 91 21
Business address
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, Switzerland, 00000
  1. 6-K Event Report of Foreign Issuer
  2. 3/A Insider 3/A
  3. 3 Insider Initial Statement of Ownership
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 4 Grant or award Director acquired 16,568 shares (grant or award)
  12. 4 Grant or award Director acquired 16,568 shares (grant or award)
  13. 4 Grant or award Interim CEO acquired 33,136 shares (grant or award)
  14. 4 Grant or award Director acquired 17,751 shares (grant or award)
  15. 4 Grant or award Director acquired 16,568 shares (grant or award)
  16. 6-K Event Report of Foreign Issuer
  17. 6-K Event Report of Foreign Issuer
  18. 4 Planned sale Chief Executive Officer sold 10,000 shares at $2.79 ($27,935)
  19. 144 Insider Sale of Securities
  20. 6-K Event Report of Foreign Issuer

Page 1 of 16 · 313 filings